OOppenheimer MMicrosoft · MSFT

Oppenheimer Keeps $630 Price Target on Microsoft

Oct 30, 2025· 1 min read· Reproduced verbatim
Rating
Buy
Price target
$630
Previous
Implied upside
+16%

Oppenheimer analyst Brian Schwartz reiterated on October 30, 2025, an ‘Outperform’ rating and $630 price target on Microsoft.

Microsoft’s F1Q results beat consensus estimates.

Azure and other Cloud Services revenue grew 39% in CC, which is strong growth at a large scale, but a slight decel from last quarter.

Additionally, the F2Q guidance for this metric implies further deceleration despite an easier y/y comparison.

The issue is capacity constraint.

Positively, management is accelerating Capex in FY26 to double the data center footprint in two years to lessen the capacity issue this fiscal year.

Bottom Line: MSFT shares are likely to retreat off the Azure F2Q guide and after moving up into the F1Q print.

Nevertheless, we recommend buying the weakness with Microsoft highly entrenched and strategically positioned for the next waves (Cloud and AI) of application modernization and expansion.

Maintain Outperform, $630 PT.”

Disclaimer
The price target and rating on this page are the opinion of the issuing research firm and its analyst, not of Price Target. This page is published for informational purposes only and is not investment advice, a recommendation, or an offer to buy or sell any security. Past performance does not guarantee future results. Consider your own circumstances and consult a licensed financial adviser before making investment decisions.

This research note is reproduced verbatim from the issuing firm. Price Target never edits, paraphrases or alters analysts’ words — we only republish them in one place.

Share

Share on
Price Target is an archive of Wall Street analyst research, published for informational purposes only. Nothing on this site is investment advice, a recommendation, or an offer to buy or sell any security. Analyst ratings and price targets are the opinions of the issuing firms, not of Price Target. Always do your own research or consult a licensed financial adviser.